{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:53:43Z","timestamp":1789523623722,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V114C-047"],"award-info":[{"award-number":["V114C-047"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-073"],"award-info":[{"award-number":["V113C-073"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-102"],"award-info":[{"award-number":["V112C-102"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-A49-044"],"award-info":[{"award-number":["111-2314-B-A49-044"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112- 2314-B-A49-029"],"award-info":[{"award-number":["NSTC 112- 2314-B-A49-029"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113\\u20132321-B-A49-011"],"award-info":[{"award-number":["113\\u20132321-B-A49-011"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jiph.2025.102836","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T12:05:14Z","timestamp":1747915514000},"page":"102836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-7529","authenticated-orcid":false,"given":"Yi-Tsung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-1652","authenticated-orcid":false,"given":"Shih-Neng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chien","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Han","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Ling","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hua","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jiph.2025.102836_bib1","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1093\/cid\/ciad547","article-title":"Priorities and progress in gram-negative bacterial infection research by the Antibacterial Resistance Leadership Group","volume":"77","author":"Satlin","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jiph.2025.102836_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.07.003","article-title":"WHO publishes updated list of bacterial priority pathogens","volume":"5","author":"Jesudason","year":"2024","journal-title":"Lancet Microbe"},{"issue":"6","key":"10.1016\/j.jiph.2025.102836_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study","volume":"20","author":"Van Duin","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jiph.2025.102836_bib4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s10096-021-04296-1","article-title":"Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions","volume":"40","author":"Tompkins","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.jiph.2025.102836_bib5","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/jac\/dkad262","article-title":"Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape","volume":"78","author":"Giacobbe","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jiph.2025.102836_bib6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/ice.2024.21","article-title":"Mortality associated with carbapenem resistance in Klebsiella pneumoniae bloodstream infection: a propensity score-matched study","volume":"45","author":"Wang","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.jiph.2025.102836_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of \u03b2-lactamase-producing pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"10.1016\/j.jiph.2025.102836_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02603-21","article-title":"Efficacy and safety of ceftazidime-avibactam for the treatment of carbapenem-resistant enterobacterales bloodstream infection: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.jiph.2025.102836_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107244","article-title":"Mechanisms and fitness of ceftazidime\/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan","volume":"64","author":"Chou","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiph.2025.102836_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10096-023-04733-3","article-title":"Emergence of OXA-48-producing hypervirulent Klebsiella pneumoniae strains in Taiwan","volume":"43","author":"Lin","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2025.102836_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102836_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jiph.2025.102836_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107186","article-title":"Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases","volume":"64","author":"Meschiari","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.jiph.2025.102836_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40121-023-00762-9","article-title":"The use and effectiveness of ceftazidime-avibactam in real-world clinical practice: EZTEAM study","volume":"12","author":"Soriano","year":"2023","journal-title":"Infect Dis Ther"},{"issue":"3","key":"10.1016\/j.jiph.2025.102836_bib15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/dkaa503","article-title":"Ceftazidime\/Avibactam Registry Study Group. Ceftazidime\/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study","volume":"76","author":"Karaiskos","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jiph.2025.102836_bib16","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/cid\/ciab176","article-title":"Ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study","volume":"73","author":"Tumbarello","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2025.102836_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106075","article-title":"Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort","volume":"56","author":"Cast\u00f3n","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiph.2025.102836_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad649","article-title":"The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: a systematic review and meta-analysis","volume":"11","author":"Lin","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiph.2025.102836_bib19","series-title":"Performance standards for antimicrobial susceptibility testing. M100","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2023"},{"issue":"10","key":"10.1016\/j.jiph.2025.102836_bib20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.mayocp.2016.06.024","article-title":"A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing enterobacteriaceae","volume":"91","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.jiph.2025.102836_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijantimicag.2019.07.017","article-title":"External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance","volume":"54","author":"Machuca","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"10.1016\/j.jiph.2025.102836_bib22","doi-asserted-by":"crossref","first-page":"915.e1","DOI":"10.1016\/j.cmi.2021.01.001","article-title":"External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients","volume":"27","author":"Papadimitriou-Olivgeris","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jiph.2025.102836_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40121-020-00288-4","article-title":"Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in patients with carbapenem-resistant enterobacteriaceae infections treated with ceftazidime-avibactam","volume":"9","author":"Jorgensen","year":"2020","journal-title":"Infect Dis Ther"},{"issue":"6","key":"10.1016\/j.jiph.2025.102836_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae273","article-title":"Outcomes and predictors of mortality in patients with KPC-Kp infections treated with meropenem vaborbactam: an observational multicenter study","volume":"11","author":"Tumbarello","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2025.102836_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02497-17","article-title":"Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant enterobacteriaceae infections","volume":"62","author":"Shields","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2025.102836_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107351","article-title":"Renal function and its impact on the concentration of ceftazidime-avibactam: a cross-sectional study","author":"Lanini","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2025.102836_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-024-02277-y","article-title":"Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis","author":"Hsu","year":"2024","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.jiph.2025.102836_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107321","article-title":"Ceftazidime\/avibactam alone or in combination with an aminoglycoside for treatment of carbapenem-resistant Enterobacterales infections: a retrospective cohort study","volume":"64","author":"Bulman","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2025.102836_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone","year":"2020","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.jiph.2025.102836_bib30","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/cid\/ciac354","article-title":"Impact of a rapid molecular test for Klebsiella pneumoniae carbapenemase and ceftazidime-avibactam use on outcomes after bacteremia caused by carbapenem-resistant enterobacterales","volume":"75","author":"Satlin","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2025.102836_bib31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10096-023-04577-x","article-title":"Cet al. Rapid diagnostics and ceftazidime\/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy","volume":"42","author":"Boattini","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102836_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10096-023-04712-8","article-title":"Prevalence and mortality of ceftazidime\/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022)","volume":"43","author":"Boattini","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.jiph.2025.102836_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad327","article-title":"Clinical characteristics and outcome of ceftazidime\/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing klebsiella pneumoniae infections: a retrospective, observational, 2-center clinical study","volume":"10","author":"Oliva","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102836_bib34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12941-025-00797-5","article-title":"Clinical and Microbiological characteristics of patients with ceftazidime\/avibactam-resistant Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae strains","volume":"24","author":"Liu","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"10.1016\/j.jiph.2025.102836_bib35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40121-025-01126-1","article-title":"Clinical characteristics of patients who acquired gram-negative bacteria during ceftazidime-avibactam therapy","volume":"14","author":"Chuang","year":"2025","journal-title":"Infect Dis Ther"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:15:35Z","timestamp":1778829335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1876034125001856"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102836","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102836"}}